State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents,2016 to 2019

Abstract

Objective:

To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019.

Method:

This study used the National Survey of Children’s Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (n=114,476), and national and state-level estimates of medication and behavioral treatment use among children with current ADHD.

Results:

The state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with current ADHD, state-level estimates of ADHD medication usage ranged from 37.8% to 81.4%, and state-level estimates of behavioral treatment ranged from 38.8% to 61.8%.

Conclusion:

There was substantial state-level variation for indicators of ADHD diagnosis and associated treatment. These state-level results can be used by policymakers, public health practitioners, health care providers, and other stakeholders to help address the service needs of children with ADHD in their states.

Keywords

ADHD behavior therapy children diagnosis medication

Get full access to this article

View all access options for this article.

References

American Academy of Child and Adolescent Psychiatry. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46(7), 894–921.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.

Andrilla

C. H. A.

Patterson

D. G.

Garberson

L. A.

Coulthard

Larson

E. H.

(2018). Geographic variation in the supply of selected behavioral health providers. American Journal of Preventive Medicine, 54(6S3), S199–S207. https://doi.org/10.1016/j.amepre.2018.01.004

Bitsko

R. H.

Claussen

A. H.

Lichstein

Black

L. I.

Everett Jones

Danielson

M. L.

Hoenig

J. M.

Jack

S. P. D.

Brody

D. J.

Gyawali

Maenner

M. J.

Warner

Holland

K. M.

Meyer

L. N.

Perou

Crosby

A. E.

Blumberg

Avenevoli

Kaminski

J. W.

Ghandour

(2022). Surveillance of children’s mental health – United States, 2013–2019. MMWR Supplements, 71(2), 1–42. https://doi.org/10.15585/mmwr.su7102a1

Blue Cross Blue Shield. (2019). The impact of attention deficit hyperactivity disorder on the health of America’s children (The Health of America Report). https://www.bcbs.com/sites/default/files/file-attachments/health-of-america-report/Health_of_America_Report-ADHD.pdf

Board

A. R.

Guy

Jones

C. M.

Hoots

(2020). Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty—United States, 2014–2019. Drug and Alcohol Dependence, 217, 108297. https://doi.org/10.1016/j.drugalcdep.2020.108297

Bokhari

F. A.

Schneider

(2011). School accountability laws and the consumption of psychostimulants. Journal of Health Economics, 30(2), 355–372. https://doi.org/10.1016/j.jhealeco.2011.01.007

Bozinovic

McLamb

O’Connell

Olander

Feng

Haagensen

Bozinovic

(2021). U.S. national, regional, and state-specific socioeconomic factors correlate with child and adolescent ADHD diagnoses pre-COVID-19 pandemic. Scientific Reports, 11(1), 22008. https://doi.org/10.1038/s41598-021-01233-2

Broder-Fingert

Sheldrick

C. R.

Silverstein

(2018). The value of state differences in autism when compared to a national prevalence estimate. Pediatrics, 142(6), e20182950. https://doi.org/10.1542/peds.2018-2950

10.

Canu

(2020). ADHD in North Carolina: Prevalence, treatment, and looking to the future. North Carolina Medical Journal, 81(2), 122–125. https://doi.org/10.18043/ncm.81.2.122

11.

Centers for Disease Control and Prevention. (2010). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007. Morbidity and Mortality Weekly Report, 59(44), 1439–1443. http://www.cdc.gov/mmwr/pdf/wk/mm5944.pdf

12.

Danielson

M. L.

Bitsko

R. H.

Ghandour

R. M.

Holbrook

J. R.

Kogan

M. D.

Blumberg

S. J.

(2018). Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. Journal of Clinical Child & Adolescent Psychology, 47(2), 199–212. https://doi.org/10.1080/15374416.2017.1417860

13.

Erskine

H. E.

Norman

R. E.

Ferrari

A. J.

Chan

G. C. K.

Copeland

W. E.

Whiteford

H. A.

Scott

J. G.

(2016). Long-term outcomes of attention-deficit/hyperactivity disorder and conduct disorder: A systematic review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 55(10), 841–850. https://doi.org/http://dx.doi.org/10.1016/j.jaac.2016.06.016

14.

Faraone

S. V.

Asherson

Banaschewski

Biederman

Buitelaar

Ramos-Quiroga

J. A.

Rohde

L. A.

Sonuga-Barke

E. J. S.

Tannock

Franke

(2015). Attention-deficit/hyperactivity disorder (ADHD). Nature Reviews Disease Primers, 1, 15–27. https://doi.org/10.1038/nrdp.2015.27

15.

Fleming

Fitton

C. A.

Steiner

M. F. C.

McLay

J. S.

Clark

King

Mackay

D. F.

Pell

J. P.

(2017). Educational and health outcomes of children treated for attention-deficit/hyperactivity disorder. JAMA Pediatrics, 171(7), e170691. https://doi.org/10.1001/jamapediatrics.2017.0691

16.

Franke

K. B.

Paton

Weist

(2021). Building policy support for school mental health in South Carolina. School Psychology Review, 50(1), 110–121. https://doi.org/10.1080/2372966X.2020.1819756

17.

Fulton

B. D.

Scheffler

R. M.

Hinshaw

S. P.

(2015). State variation in increased ADHD prevalence: Links to NCLB school accountability and state medication laws. Psychiatric Services, 66(10), 1074–1082. https://doi.org/10.1176/appi.ps.201400145

18.

Fulton

B. D.

Scheffler

R. M.

Hinshaw

S. P.

Levine

Stone

Brown

T. T.

Modreck

(2009). National variation of ADHD diagnostic prevalence and medication use: Health care providers and education policies. Psychiatric Services, 60(8), 1075–1083. https://doi.org/10.1176/ps.2009.60.8.1075

19.

Ghandour

R. M.

Jones

J. R.

Lebrun-Harris

L. A.

Minnaert

Blumberg

S. J.

Fields

Bethell

Kogan

M. D.

(2018). The design and implementation of the 2016 National Survey of Children’s Health. Maternal and Child Health Journal, 22, 1093–1102. https://doi.org/10.1007/s10995-018-2526-x

20.

Harati

P. M.

Cummings

J. R.

Serban

(2020). Provider-level caseload of psychosocial services for Medicaid-insured children. Public Health Reports, 135(5), 599–610. https://doi.org/10.1177/0033354920932658

21.

Hechtman

Swanson

J. M.

Sibley

M. H.

Stehli

Owens

E. B.

Mitchell

J. T.

Arnold

L. E.

Molina

B. S.

Hinshaw

S. P.

Jensen

P. S.

Abikoff

H. B.

Perez Algorta

Howard

A. L.

Hoza

Etcovitch

Houssais

Lakes

K. D.

Nichols

J. Q.

, & MTA Cooperative Group. (2016). Functional adult outcomes 16 years after childhood diagnosis of attention-deficit/hyperactivity disorder: MTA results. Journal of the American Academy of Child & Adolescent Psychiatry, 55(11), 945–952.e2. https://doi.org/10.1016/j.jaac.2016.07.774

22.

Hulkower

R. L.

Kelley

Cloud

L. K.

Visser

S. N.

(2017). Medicaid prior authorization policies for medication treatment of attention-deficit/hyperactivity disorder in young children, United States, 2015. Public Health Reports, 132(6), 654–659. https://doi.org/10.1177/0033354917735548

23.

Korn

E. L.

Graubard

B. I.

(1998). Confidence intervals for proportions with small expected number of positive counts estimated from survey data. Survey Methodology, 24, 193–201.

24.

Kumar

Gleason

M. M.

(2019). Pediatric attention-deficit/hyperactivity disorder in Louisiana: Trends, challenges, and opportunities for enhanced quality of care. Ochsner Journal, 19(4), 357–368. https://doi.org/10.31486/toj.18.0103

25.

Larkin

Ang

Steinhart

Chao

Patterson

Sah

Schoenbaum

Hutchins

Brennan

Loewenstein

(2017). Association between academic medical center pharmaceutical detailing policies and physician prescribing. JAMA, 317(17), 1785–1795. https://doi.org/10.1001/jama.2017.4039

26.

Lindly

O. J.

Eaves

M. C.

Tarazi

C. L.

Rao

S. R.

Kuhlthau

K. A.

(2022). Therapy use for U.S. school-aged children with developmental disabilities: State variation and determinants. Disability and Health Journal, 15(1), 101198. https://doi.org/10.1016/j.dhjo.2021.101198

27.

McBain

R. K.

Kofner

Stein

B. D.

Cantor

J. H.

Vogt

W. B.

(2019). Growth and distribution of child psychiatrists in the United States: 2007–2016. Pediatrics, 144(6), e20191576. https://doi.org/10.1542/peds.2019-1576

28.

McDonald

D. C.

Jalbert

S. K.

(2013). Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008. Psychiatric Services, 64(11), 1079–1086. https://doi.org/10.1176/appi.ps.004442012

29.

Morrill

M. S.

(2018). Special education financing and ADHD medications: A bitter pill to swallow. Journal of Policy Analysis and Management, 37(2), 384–402. https://doi.org/10.1002/pam.22055

30.

Office of the Surgeon General. (2021). Protecting youth mental health: The U.S. Surgeon General’s Advisory. https://www.hhs.gov/sites/default/files/surgeon-general-youth-mental-health-advisory.pdf

31.

Parker

J. D.

Talih

Malec

D. J.

Beresovsky

Carroll

Joe Fred Gonzalez

Hamilton

B. E.

Ingram

D. D.

Kochanek

McCarty

Moriarity

Shimizu

Strashny

Ward

B. W.

(2017). National Center for Health Statistics data presentation standards for proportions. Vital and Health Statistics, Series 2. National Center for Health Statistics.

32.

Piper

B. J.

Ogden

C. L.

Simoyan

O. M.

Chung

D. Y.

Caggiano

J. F.

Nichols

S. D.

McCall

K. L.

(2018). Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PLoS ONE, 13(11), e0206100. https://doi.org/10.1371/journal.pone.0206100

33.

Public Health Informatics Institute. (2021). Using data to improve child and adolescent mental health (CAMH): The opening playbook. Retrieved November 4, 2021 from https://phii.org/course/using-data-to-improve-child-and-adolescent-mental-health-camh-the-opening-playbook/

34.

Scally

C. P.

Pettit

K. L. S.

Arena

(2017). 500 cities project: Local data for better health. Urban Institute. https://www.urban.org/sites/default/files/publication/90376/500-cities-project_1.pdf

35.

Schor

E. L.

Johnson

(2021). Child health inequities among state Medicaid programs. JAMA Pediatrics, 175(8), 775–776. https://doi.org/10.1001/jamapediatrics.2021.1082

36.

Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management; Wolraich

Brown

R. T.

DuPaul

Earls

Feldman

H. M.

Ganiats

T. G.

Kaplanek

Meyer

Perrin

Pierce

Reiff

Stein

M. T.

Visser

(2011). ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128(5), 1007–1022. https://doi.org/10.1542/peds.2011-2654

37.

Tseregounis

I. E.

Stewart

S. L.

Crawford

Marshall

B. D. L.

Cerdá

Shev

A. B.

Henry

S. G.

(2020). Age- and sex-specific increases in stimulant prescribing rates—California, 2008–2017. Journal of Attention Disorders, 24(2), 205–214. https://doi.org/10.1177/1087054719883008

38.

United States Census Bureau. (2017). 2016 National Survey of Children’s Health: Nonresponse bias analysis. https://www.census.gov/content/dam/Census/programs-surveys/nsch/tech-documentation/nonresponse-bias-analysis/NSCH%202016%20Nonresponse%20Bias%20Analysis.pdf

39.

United States Census Bureau. (2018a). 2016 National Survey of Children’s Health: Methodology report. https://www.census.gov/content/dam/Census/programs-surveys/nsch/tech-documentation/methodology/2016-NSCH-Methodology-Report.pdf

40.

United States Census Bureau. (2018b). 2017 National Survey of Children’s Health: Methodology report. https://www.census.gov/content/dam/Census/programs-surveys/nsch/tech-documentation/methodology/2017-NSCH-Methodology-Report.pdf

41.

United States Census Bureau. (2019). 2018 National Survey of Children’s Health: Methodology report. https://www2.census.gov/programs-surveys/nsch/technical-documentation/methodology/2018-NSCH-Methodology-Report.pdf

42.

United States Census Bureau. (2020). 2019 National Survey of Children’s Health: Methodology report. https://www2.census.gov/programs-surveys/nsch/technical-documentation/methodology/2019-NSCH-Methodology-Report.pdf

43.

Visser

S. N.

Bitsko

R. H.

Danielson

M. L.

Ghandour

R. M.

Blumberg

S. J.

Schieve

L. A.

Holbrook

J. R.

Wolraich

M. L.

Cuffe

S. P.

(2015). Treatment of attention deficit/hyperactivity disorder among children with special health care needs. The Journal of Pediatrics, 166(6), 1423–1430.e1422. https://doi.org/10.1016/j.jpeds.2015.02.018

44.

Visser

S. N.

Blumberg

S. J.

Danielson

M. L.

Bitsko

R. H.

Kogan

M. D.

(2013). State-based and demographic variation in parent-reported medication rates for attention-deficit/hyperactivity disorder, 2007–2008. Preventing Chronic Disease, 10, E09. https://doi.org/10.5888/pcd9.120073

45.

Visser

S. N.

Danielson

M. L.

Bitsko

R. H.

Holbrook

J. R.

Kogan

M. D.

Ghandour

R. M.

Perou

Blumberg

S. J.

(2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry, 53(1), 34–46.e32. https://doi.org/10.1016/j.jaac.2013.09.001

46.

Visser

S. N.

Danielson

M. L.

Bitsko

R. H.

Perou

Blumberg

S. J.

(2013). Convergent validity of parent-reported attention-deficit/hyperactivity disorder diagnosis: A cross-study comparison. JAMA Pediatrics, 167(7), 674–675. https://doi.org/10.1001/jamapediatrics.2013.2364

47.

Visser

S. N.

Danielson

M. L.

Wolraich

M. L.

Fox

M. H.

Grosse

S. D.

Valle

L. A.

Holbrook

J. R.

Claussen

A. H.

Peacock

(2016). Vital Signs: National and state-specific patterns of attention deficit/hyperactivity disorder treatment among insured children aged 2–5 years—United States, 2008–2014. Morbidity and Mortality Weekly Report, 65(17), 443–450. https://doi.org/10.15585/mmwr.mm6517e1

48.

Whitney

D. G.

Peterson

M. D.

(2019). US national and state-level prevalence of mental health disorders and disparities of mental health care use in children. JAMA Pediatrics, 173(4), 389–391. https://doi.org/10.1001/jamapediatrics.2018.5399

49.

Wolraich

M. L.

Hagan

J. F.

Allan

Chan

Davison

Earls

Evans

S. W.

Flinn

S. K.

Froehlich

Frost

Holbrook

J. R.

Lehmann

C. U.

Lessin

H. R.

Okechukwu

Pierce

K. L.

Winner

J. D.

Zurhellen

; & Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528